Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/10/1999 | WO1999044625A1 Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation |
09/10/1999 | WO1999044620A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
09/10/1999 | WO1999035263A3 Il-17rh dna and polypeptides |
09/10/1999 | WO1999033991A3 TOXINS ACTIVE AGAINST $i(OSTRINIA NUBILALIS) |
09/10/1999 | WO1999033967A3 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
09/10/1999 | WO1999033866A3 Antivirally active oligopeptide isolated from royal jelly |
09/10/1999 | WO1999032644A3 Prostate cancer gene |
09/10/1999 | WO1999032622A3 Semaphorin zsmf-3 |
09/10/1999 | WO1999032515A3 Angiopoietin homolog, dna encoding it, and method of making it |
09/10/1999 | WO1999032514A3 Sag: sensitive to apoptosis gene |
09/10/1999 | WO1999032428A3 Synthesis of diamines |
09/10/1999 | WO1999031236A3 EXTENDED cDNAs FOR SECRETED PROTEINS |
09/10/1999 | WO1999029890A3 Assessment of human papilloma virus-related disease |
09/10/1999 | WO1999028466A9 Compositions and methods of use of het |
09/10/1999 | WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
09/10/1999 | WO1999027889A3 Non-toxic immune stimulating enterotoxin compositions |
09/10/1999 | WO1999027102A9 Cd4+ t-lymphocyte protease genes and inhibitors thereof |
09/10/1999 | WO1999025829A3 Cdk2 protein and cdk2 protein complexes |
09/10/1999 | WO1999021992A3 Nucleic acid molecules encoding a glutamate receptor |
09/10/1999 | WO1999020756A3 Human toll homologues |
09/10/1999 | WO1999020644A9 Secreted proteins and polynucleotides encoding them |
09/10/1999 | WO1999010487A9 Novel transcriptional regulators and uses therefor |
09/10/1999 | WO1999001548A3 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
09/10/1999 | WO1998053839A3 Anti-cancer products for treating cystic fibrosis |
09/10/1999 | WO1998005356A8 NOVEL FtsL |
09/10/1999 | CA2326408A1 Epitope peptides immunogenic against streptococcus pneumoniae |
09/10/1999 | CA2322846A1 Improved method for purifying cholera toxin |
09/10/1999 | CA2322749A1 Cd147 binding molecules as therapeutics |
09/10/1999 | CA2322731A1 Lectomedin materials and methods |
09/10/1999 | CA2322719A1 Genetic sequences conferring pathogen resistance in plants and uses therefor |
09/10/1999 | CA2322665A1 Delivery of proteins into eukaryotic cells with recombinant yersinia |
09/10/1999 | CA2322621A1 V-like domain binding molecules |
09/10/1999 | CA2322592A1 Use of a peptide or antibody in the manufacture of a medicament for treating an erbb protein medicated tumor in combination with irradiation |
09/10/1999 | CA2322505A1 Production of mycobacterial polypeptides by lactic acid bacteria |
09/10/1999 | CA2322426A1 Diagnostic for metastatic prostate cancer |
09/10/1999 | CA2322425A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
09/10/1999 | CA2322382A1 Method for the induction of pathogen resistance in plants |
09/10/1999 | CA2322381A1 Human synapse related glycoproteins (hsrp) |
09/10/1999 | CA2321996A1 Chimeric proteins with cell-targeting specificity and apoptosis-inducingactivities |
09/10/1999 | CA2321171A1 Conjugates useful in the treatment of prostate cancer |
09/10/1999 | CA2265069A1 Oral immunity enhancing agent |
09/10/1999 | CA2264970A1 Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
09/10/1999 | CA2249661A1 Novel compounds |
09/10/1999 | CA2249041A1 Novel compounds |
09/08/1999 | EP0940470A2 A fusion protein and its use for the simultaneous detection of autoantibodies related to insulin-dependent diabetes mellitus |
09/08/1999 | EP0940469A2 Cloning by complementation and related processes |
09/08/1999 | EP0940468A1 Humanized antibody variable domain |
09/08/1999 | EP0940467A1 Promoters for swine complement inhibitors |
09/08/1999 | EP0939835A1 Compositions and methods for treating viral infections |
09/08/1999 | EP0939832A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
09/08/1999 | EP0939828A1 Herpesvirus saimiri as viral vector |
09/08/1999 | EP0939826A2 Delivery of tolerogenic antigens via edible plants or plant-derived products |
09/08/1999 | EP0939825A1 Truncated cbh i promoter from trichoderma reesei and use thereof |
09/08/1999 | EP0939824A1 Reagents and methods useful for detecting diseases of the breast |
09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
09/08/1999 | EP0939820A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof |
09/08/1999 | EP0939819A1 Mini-e1a genes and gene products |
09/08/1999 | EP0939818A1 Recombinant toxin fragments |
09/08/1999 | EP0939817A2 High-affinity interleukin-4 muteins |
09/08/1999 | EP0939816A1 Circularly permuted erythropoietin receptor agonists |
09/08/1999 | EP0939815A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION |
09/08/1999 | EP0939814A1 Fringe proteins and notch signalling |
09/08/1999 | EP0939813A1 Breast carcinoma-associated gene |
09/08/1999 | EP0939812A2 Novel human macrophage antigen |
09/08/1999 | EP0939811A1 Recombinant plant cells expressing heterochromatin 1 (hp1) of drosophila melanogaster |
09/08/1999 | EP0939810A2 Transcriptional intermediary factor-2 tif2 |
09/08/1999 | EP0939809A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
09/08/1999 | EP0939808A1 Spruce budworm antifreeze proteins, genes and methods of using same |
09/08/1999 | EP0939807A2 Secreted proteins and polynucleotides encoding them |
09/08/1999 | EP0939806A1 Fanconi gene 1 |
09/08/1999 | EP0939805A2 Secreted proteins and polynucleotides encoding them |
09/08/1999 | EP0939804A1 NEUTROKINE alpha |
09/08/1999 | EP0939802A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
09/08/1999 | EP0939770A1 Receptor specific brain natriuretic peptide (bnp) |
09/08/1999 | EP0939769A1 Vertebrate smoothened proteins |
09/08/1999 | EP0939768A1 High-affinity salicylic acid-binding protein |
09/08/1999 | EP0939767A1 Modified factor viii |
09/08/1999 | EP0939766A2 Synthesis of soluble beta-sheet forming peptides |
09/08/1999 | EP0939764A2 Molecular genetic construction of vaccine strains of pasteurellaceae |
09/08/1999 | EP0939761A1 Salmonella secreted proteins and uses thereof |
09/08/1999 | EP0939646A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
09/08/1999 | EP0939643A1 Immunomodulating compounds comprising d-isomers of amino acids |
09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
09/08/1999 | EP0939627A1 Pentafluorobenzenesulfonamides and analogs |
09/08/1999 | EP0939590A1 Delivery of therapeutic gene products by intestinal cell expression |
09/08/1999 | EP0939589A2 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin |
09/08/1999 | EP0871463A4 Regulation of eating behavior |
09/08/1999 | EP0738329A4 Hybrid cytokines |
09/08/1999 | EP0722460B1 Derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
09/08/1999 | EP0699306B1 Assay for cardiac troponin i |
09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
09/08/1999 | EP0637968B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
09/08/1999 | EP0583352B1 hGPIIb FRAGMENTS AND THEIR USE IN $i(IN VITRO) METHODS FOR DETERMINING $i(IN VIVO) THROMBOTIC EVENTS |
09/08/1999 | EP0546022B1 High viscosity bacteria, bacterial compositions, and methods |
09/08/1999 | EP0353250B1 The engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins |
09/08/1999 | CN1228123A Peptide with inhibitory activity towards plant pathogenic fungi |
09/08/1999 | CN1228122A Method for immortalizing cells |
09/08/1999 | CN1228121A Method for mass production of antimicrobial peptide |
09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
09/08/1999 | CN1227870A Genes of purine biosynthesis from ashbya gossypli and use thereof in microbial riboflavin synthesis |